Regen BioPharma, Inc. (RGBPP)

Market Cap	800.83K
Revenue (ttm)	236.56K
Net Income (ttm)	-867.25K
Shares Out	n/a
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,811
Average Volume	17,920
Open	0.0630
Previous Close	0.0560
Day's Range	0.0510 - 0.0630
52-Week Range	0.0300 - 0.4800
Beta	n/a
RSI	45.30
Earnings Date	n/a

About Regen BioPharma

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is also developing HemaXellarate, a cellular therapeutic product of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase;...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2012
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: RGBPP